A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Neoplasms

Interventions

DRUG

aflibercept (AVE0005)

intravenous infusion

DRUG

docetaxel

intravenous infusion

Trial Locations (2)

Sanofi-Aventis Investigational Site Number 392002, Iruma-gun

Sanofi-Aventis Investigational Site Number 392001, Sunto-Gun